TOP-5 Price Targets of Analysts on January 14, 2026
Reading Time: 3 minutes
MDxHealth [BE0974461940] Lake Street confirms Buy rating with a price target of 9 USD (148% upside potential) The background for the buy recommendation is the better-than-expected growth forecasts for the ongoing fourth quarter and for the overall year 2025, as well as the optimistic outlook for 2026. Both in the fourth quarter and for the full year 2025, revenue growth is expected to exceed 20%. For the year 2026, MDxHealth anticipates revenue between 137 and 140 million USD, representing an increase of about 26% to 28% compared to...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
